ArticleCancer immunology, immunotherapy : CII2023

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.

Ondřej Fiala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.